Home/Filings/4/0001209191-20-020121
4//SEC Filing

Kouchakji Elias 4

Accession 0001209191-20-020121

CIK 0000921299other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 8:03 PM ET

Size

9.0 KB

Accession

0001209191-20-020121

Insider Transaction Report

Form 4
Period: 2020-03-06
Kouchakji Elias
SVP, Clinical Dev, Drug Safety
Transactions
  • Tax Payment

    Common Stock

    2020-03-06$39.71/sh6,525$259,10894,691 total
  • Award

    Stock Option (Right to Buy)

    2020-03-17+62,50062,500 total
    Exercise: $26.41Exp: 2030-03-17Common Stock (62,500 underlying)
  • Award

    Common Stock

    2020-03-17+37,500132,191 total
Footnotes (3)
  • [F1]Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
  • [F2]Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years.
  • [F3]Twenty-five percent of the shares subject to the option vests March 1, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years.

Issuer

FIBROGEN INC

CIK 0000921299

Entity typeother

Related Parties

1
  • filerCIK 0001775259

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 8:03 PM ET
Size
9.0 KB